Bronchial Wash Cytology
Bronchial Wash Cytology - Related Videos
03:39
Preparation of Formalin-Fixed Paraffin-Embedded Tumor Samples: A Protocol to Preserve Tissue and Cytology Samples from Non-small Cell Lung Cancer (NSCLC)
0 Views •
2023
This protocol describes the preparation of formalin-fixed paraffin-embedded tumor samples which are used to preserve tissue and cytology samples from non-small cell lung cancer...
07:01
Impression Cytology of the Lid Wiper Area
0 Views •
Cited by 3 •
2016
We collected, stained and imaged cells from the conjunctiva of the inner eyelid margin of human subjects. By characterizing cell morphology and metabolic activity, this method may further our understanding of dry eye and the role that friction between the ocular surfaces may play in perceiving ocular discomfort.
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
0 Views •
Cited by 4 •
2010
Bronchial thermoplasty is a non-drug procedure for severe persistent asthma that delivers thermal energy to the airway wall in a precisely controlled manner to reduce excessive airway smooth muscle. Reducing airway smooth muscle decreases the ability of the airways to constrict, thereby reducing the frequency of asthma attacks.
14:32
Primary Human Bronchial Epithelial Cells Grown from Explants
0 Views •
Cited by 19 •
2010
Here we describe a detailed method for growing primary human bronchial epithelial cells from explants of human bronchial airway tissue including differentiated growth on an air-liquid interface. This method provides an abundant source of primary cells for investigating the role of the airway epithelium in human lung health and disease.
08:09
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
0 Views •
Cited by 11 •
2017
We explored a tubal cytologic method by sampling the fallopian tube directly post-surgical excision as a tool of ovarian cancer early detection. Here, we present a protocol to collect fallopian tube cells from freshly received surgical specimens.
FAQs
Researchers assess more than the presence of unusual cells. They examine abnormal nuclei, changes in how cells are organized, and malignant morphology, meaning cellular appearances associated with cancer. Considering these features together helps distinguish tumor-associated changes within airway material and supports the classification of cytologic findings for cancer research.
A cytologic assessment examines shed airway cells, whereas tissue-based results provide a separate reference for evaluating those observations. Comparing the two can reveal how cellular features identified in wash material correspond to findings in tissue. In cancer research, this supports more informed classification of tumor-associated changes and helps assess the diagnostic relevance of cytologic observations.
Airway biomarkers provide an additional research focus beyond microscopic assessment of cell appearance. Investigating these markers in recovered airway material can help researchers relate cellular abnormalities to disease development and treatment response. This approach also supports studies that connect cytologic observations with broader patterns of tumor-associated change in respiratory disease.
After the bronchial fluid is aspirated, the recovered material undergoes laboratory processing before evaluation. Researchers prepare the specimen, apply stains, and examine it microscopically for abnormal nuclei, altered cell organization, and malignant morphology. These steps convert the collected fluid into interpretable cellular evidence that can support cancer-related analysis.
Selecting a bronchial segment establishes the airway source of the recovered specimen. That location matters because cytologic findings can then be considered in relation to the bronchial area examined, rather than treated as unlocalized material. This supports organized sampling and interpretation when researchers investigate tumor-associated changes or compare cytology with tissue-based results.
Researchers can apply the method when they need minimally invasive cellular evidence related to respiratory disease, including lung cancer. In cancer studies, its outputs can support detection and classification of tumor-associated changes, comparison with tissue findings, and investigation of airway biomarkers. The same evidence can help relate cellular abnormalities to disease development and treatment response.